AXIM Biotech focuses on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. AXIM flagship products include CanChew Plus, a CBD-based controlled-release chewing gum containing 10mg of hemp-derived CBD, CanChew+ 50™, containing 50 mg of CBD undergoing clinical trials in patients with IBS, and MedChew Rx™, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. AXIM Biotechnologies was founded in 2010 and is based in San Diego, California.